Question explored with the scientific record
Conversation so far
- 1 What is the expected timeline for post-vaccination encephalitis after MMR, Varicella, and Hep A vaccines assuming the encephalitis was caused by the vaccines?
- 2 Could 48 hours by theoretically plausible? How?
- 3 What immune mediated response could lead to encephalitis 48 hours post vaccination?
- 4 Do any vaccines support encephalitis at 48 hours?
- 5 Which vaccines had encephalitis onset closest to 48 hours?
Answered on this page ↓
Which vaccines had encephalitis onset closest to 48 hours?
The retrieved evidence does not contain any case of encephalitis with onset at exactly 48 hours after any vaccine.
The closest documented timing is in the COVID-19 vaccine literature, where a case report describes a 72-year-old man with confusion starting 1 day after the first BNT162b2 dose and a Nigerian woman developing suspected autoimmune limbic encephalitis 2 days after the second AstraZeneca dose [4]. Neither is precisely 48 hours, and both are from the previous answer's sources, not from this retrieval.
For childhood vaccines, the evidence here shows no encephalitis cases at any specific hour. The MMR fever peak is at 9-10 days [2], and record-linkage studies looked at encephalitis within 3 months, not at 48 hours [2]. The varicella vaccine strain can cause meningitis and encephalitis, but the case series reports onset in days to weeks, not hours [3].
The IFNAR2 deficiency case documents fatal encephalitis after MMR, but the timing is not given as 48 hours [1]. That case is about a genetic vulnerability, not a specific onset window.
My call: no vaccine in this retrieval has a documented encephalitis case with onset at exactly 48 hours. The closest windows are 1-2 days after COVID-19 vaccines, but the evidence does not support a precise 48-hour pattern for any vaccine. Confidence: low — the retrieval is thin and the question asks for a precision the literature does not provide.
Sources used 4
-
Human IFNAR2 deficiency: Lessons for antiviral immunity
This study identifies a homozygous mutation in the IFNAR2 gene in a child with fatal encephalitis following MMR vaccination, highlighting the critical role of type I interferons in human antiviral immunity.
DOI: 10.1126/scitranslmed.aac4227 -
MMR vaccine - how effective and how safe?
This narrative review assesses the effectiveness and safety of the MMR vaccine, concluding that it is highly protective against measles, mumps, and rubella, and that current evidence does not support a causal link between MMR vaccination and inflammatory bowel disease or autism.
DOI: 10.1136/dtb.2003.41425 -
Varicella-Zoster Disease of the Central Nervous System in Immunocompetent Children: Case Series and a Scoping Review
This study analyzes the clinical manifestations and outcomes of Varicella-Zoster Virus (VZV) reactivation in the central nervous system (CNS) of immunocompetent children, revealing that both wild-type and vaccine strains can cause meningitis and encephalitis, often without a typ…
DOI: 10.3390/vaccines12091086 -
Mecanismo y diseño de vacunas para el sars-cov-2, revisión narrativa
This narrative review describes SARS-CoV-2 vaccine mechanisms and designs, reporting that mRNA vaccines (BNT162b2 and mRNA-1273) demonstrate the highest efficacy (93-95%), adenovirus vector vaccines show 66.9-91.6% efficacy, and inactivated CoronaVac shows 83.5%, with rare safet…
DOI: 10.18566/medupb.v43n1.a10